Stock Earnings Examining the Potential Price Growth of Regeneron Pharmaceuticals, Inc. (REGN) Regeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.22 million on May
Insiders Updates Analysts review Regeneron Pharmaceuticals, Inc.’s rating Regeneron Pharmaceuticals, Inc.’s recently made public that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.22 million on
Stock Earnings Checking in on Regeneron Pharmaceuticals, Inc. (REGN) after recent insiders movement Regeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.24 million on Apr
Stock Earnings Regeneron Pharmaceuticals, Inc. [NASDAQ: REGN] Sees Decrease in Stock Value The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or